Insulin Glargine Injection, Solution
Product Images NDC 83257-014
Product Visual Gallery
This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Insulin Glargine (NDC 83257-014). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Biologics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Injection-image (Injection Image)
Image-36 (Image 36)
Image-37 (Image 37)
Glucose-lowering Effect Over 24 Hours In Patients With Type 1 Diabetes (Image 01)
Step 1 (Image 02)
Step 2 (Image 03)
Step 3 (Image 04)
Step 4 (Image 05)
Step 5 (Image 06)
Step 7 (Image 07)
Step 8 (Image 08)
Places To Inject (Image 09)
Figure A (Image 11)
Figure B (Image 12)
Figure C (Image 13)
Figure D (Image 14)
Figure E (Image 15)
Figure F (Image 16)
Figure G (Image 17)
Figure H (Image 18)
Figure I (Image 19)
Figure J (Image 20)
Figure K (Image 21)
Figure L (Image 22)
Figure M (Image 23)
Figure N (Image 24)
Figure O (Image 25)
Figure P (Image 26)
Figure Q (Image 27)
Figure R (Image 28)
Figure S (Image 29)
Figure T (Image 30)
Figure U (Image 31)
Figure V (Image 32)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.